BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34053988)

  • 1. Acute Megakaryoblastic Leukemia Harboring a Subclone Expressing BCR-ABL1 Fusion Gene Product.
    Kashima E; Nakano E; Watanabe Y; Imai H; Oka K; Kageyama S; Tanaka I
    Intern Med; 2021 Nov; 60(22):3609-3614. PubMed ID: 34053988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with
    Boucher L; Sorel N; Desterke C; Chollet M; Rozalska L; Gallego Hernanz MP; Cayssials E; Raimbault A; Bennaceur-Griscelli A; Turhan AG; Chomel JC
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
    Rosenberg MW; Savage SL; Eide CA; Reister Schultz A; Cook RJ; Press RD; Rempfer C; Eickelberg G; Wilmot B; McWeeney SK; Tyner JW; Druker BJ; Tognon CE
    Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36307214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.
    Neuendorff NR; Schwarz M; Hemmati P; Türkmen S; Bommer C; Burmeister T; Dörken B; le Coutre P; Arnold R; Westermann J
    Acta Haematol; 2015; 133(2):237-41. PubMed ID: 25401297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
    Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
    Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia.
    Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA
    Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute megakaryoblastic leukaemia with extreme thrombocytosis and p190(bcr/abl)rearrangement.
    Balatzenko G; Guenova M; Zechev J; Toshkov S
    Ann Hematol; 2004 Jun; 83(6):381-5. PubMed ID: 14615910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
    Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
    Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
    BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
    Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
    Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
    Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE
    Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.
    Pullarkat ST; Vardiman JW; Slovak ML; Rao DS; Rao NP; Bedell V; Said JW
    Leuk Res; 2008 Nov; 32(11):1770-5. PubMed ID: 18417213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia.
    Chandran RK; Geetha N; Sakthivel KM; Aswathy CG; Gopinath P; Raj TVA; Priya G; Nair JKKM; Sreedharan H
    Gene; 2019 Feb; 686():85-91. PubMed ID: 30399426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome.
    Vandenberghe E; Martiat P; Baens M; Stul M; Ferrant A; Cuneo A; Cassiman JJ; Mecucci C; Van den Berghe H
    Leukemia; 1991 Aug; 5(8):683-6. PubMed ID: 1886421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Philadelphia-positive acute lymphoblastic leukemia with multiple subclones including duplication of the Philadelphia chromosome and Abelson oncogene.
    La Starza R; Vitale A; Serra A; Saglio G; Fioritoni G; Falzetti D; Martelli MF; Foà R; Mecucci C
    Cancer Genet Cytogenet; 2002 Jan; 132(1):46-50. PubMed ID: 11801308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient.
    Zámečníkova A; Al Bahar S; Pandita R
    Hematology; 2012 Nov; 17(6):321-4. PubMed ID: 22989955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome.
    Min X; Na Z; Yanan L; Chunrui L
    J Hematol Oncol; 2011 Nov; 4():45. PubMed ID: 22075327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1
    Mian AA; Haberbosch I; Khamaisie H; Agbarya A; Pietsch L; Eshel E; Najib D; Chiriches C; Ottmann OG; Hantschel O; Biondi RM; Ruthardt M; Mahajna J
    Ann Hematol; 2021 Aug; 100(8):2023-2029. PubMed ID: 34110462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Philadelphia chromosome positive acute myeloid leukemia: A case report.
    Shao X; Chen D; Xu P; Peng M; Guan C; Xie P; Yuan C; Chen B
    Medicine (Baltimore); 2018 Nov; 97(44):e12949. PubMed ID: 30383645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.